Canagliflozin protects against hyperglycemia-induced cerebrovascular injury by preventing blood-brain barrier (BBB) disruption via AMPK/Sp1/adenosine A2A receptor

卡格列净 腺苷 血脑屏障 安普克 小干扰RNA 医学 腺苷A2A受体 药理学 内科学 化学 腺苷受体 内分泌学 受体 糖尿病 中枢神经系统 2型糖尿病 蛋白激酶A 生物化学 转染 激酶 兴奋剂 基因
作者
Zhiyi Liu,Wei Hua,Sinan Jin,Yueying Wang,Yuxin Pang,Benshuai Wang,Nan Zhao,Yuejia Song,Jiping Qi
出处
期刊:European Journal of Pharmacology [Elsevier BV]
卷期号:968: 176381-176381 被引量:12
标识
DOI:10.1016/j.ejphar.2024.176381
摘要

Diabetes mellitus causes brain microvascular endothelial cell (MEC) damage, inducing dysfunctional angiogenic response and disruption of the blood-brain barrier (BBB). Canagliflozin is a revolutionary hypoglycemic drug that exerts neurologic and/or vascular-protective effects beyond glycemic control; however, its underlying mechanism remains unclear. In the present study, we hypothesize that canagliflozin ameliorates BBB permeability by preventing diabetes-induced brain MEC damage. Mice with high-fat diet/streptozotocin-induced diabetes received canagliflozin for 8 weeks. We assessed vascular integrity by measuring cerebrovascular neovascularization indices. The expression of specificity protein 1 (Sp1), as well as tight junction proteins (TJs), phosphorylated AMP-activated protein kinase (p-AMPK), and adenosine A2A receptors was examined. Mouse brain MECs were grown in high glucose (30 mM) to mimic diabetic conditions. They were treated with/without canagliflozin and assessed for migration and angiogenic ability. We also performed validation studies using AMPK activator (AICAR), inhibitor (Compound C), Sp1 small interfering RNA (siRNA), and adenosine A2A receptor siRNA. We observed that cerebral pathological neovascularization indices were significantly normalized in mice treated with canagliflozin. Increased Sp1 and adenosine A2A receptor expression and decreased p-AMPK and TJ expression were observed under diabetic conditions. Canagliflozin or AICAR treatment alleviated these changes. However, this alleviation effect of canagliflozin was diminished again after Compound C treatment. Either Sp1 siRNA or adenosine A2A receptor siRNA could increase the expression of TJs. Luciferase reporter assay confirmed that Sp1 could bind to the adenosine A2A receptor gene promoter. Our study identifies the AMPK/Sp1/adenosine A2A receptor pathway as a treatment target for diabetes-induced cerebrovascular injury.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
开朗灵寒完成签到,获得积分10
1秒前
1秒前
海清河晏完成签到,获得积分10
2秒前
科研通AI6.2的应助被珉志采纳,获得10
3秒前
Akim的应助被朵拉A梦采纳,获得10
3秒前
whistle完成签到,获得积分10
3秒前
Jasper的应助被韦智杰采纳,获得10
4秒前
yuC完成签到,获得积分10
4秒前
梦雅完成签到,获得积分10
4秒前
oioiiio发布了新的文献求助10
4秒前
经十路以东的应助被Meiyu采纳,获得10
5秒前
yy发布了新的文献求助10
5秒前
皮夏寒发布了新的文献求助10
5秒前
5秒前
ding完成签到,获得积分10
6秒前
自然的哈密瓜完成签到,获得积分10
7秒前
8秒前
辉099411完成签到,获得积分10
8秒前
健壮的化蛹完成签到,获得积分10
8秒前
9秒前
一米七的小柯基完成签到,获得积分10
11秒前
小慧慧完成签到 ,获得积分10
11秒前
11秒前
科研通AI6.2的应助被喷火龙采纳,获得10
11秒前
11秒前
clevenx发布了新的文献求助10
12秒前
13秒前
无题完成签到,获得积分10
13秒前
15秒前
15秒前
16秒前
温夜天完成签到,获得积分10
16秒前
16秒前
星辰大海的应助被皮夏寒采纳,获得10
16秒前
16秒前
17秒前
开朗含海完成签到,获得积分10
17秒前
18秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264